[Comparative study on the effect of administration of vaginal and endocervical prostaglandin E2].
Bozhinova
S
S
Porozhanova
V
V
Khristova
V
V
D000282:Administration, Intravaginal; D000287:Administration, Topical; D002584:Cervix Uteri; D015232:Dinoprostone / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007751:Labor, Induced / Q000379:methods*; D011247:Pregnancy
D015232:Dinoprostone